TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
CGEN

Compugen

Healthcare · Biotechnology

2.40$ +0.9% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Compugen (CGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 157 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CGEN
Line item 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
16 98 87 77 68 55 42 31 22 14 30 36 29 29 57 115 99 71 39 53 54 138 132 94 121 115 157
13 94 36 53 18 22 32 26 16 8.2 24 28 23 26 53 75 91 63 31 47 45 129 123 86 115 106 148
11 81 8.4 5.3 7.9 4.4 0.7 6.3 1.4 5.4 15 7.3 5.8 20 47 73 81 62 30 46 9.8 7.1 7.8 11 14 18 91
11 81 18 18 17 21 31 25 15 11 15 22 22 25 51 74 82 62 30 46 44 124 117 83 51 103 146
0.7 2.7 3.0 4.6 0.6 1.0 0.4 0.3 0.4 0.6 8.5 5.6 0.3 0.2 1.2 0.4 8.4 0.1 0.7 0.2 0.3 2.0 0.2 0.3 61 0.3 0.3
0.4 0.4 0.3 0.1 0.6 0.6 1.1 – 0.3 -12 -15 -21 -22 -0.5 -0.6 -1.0 -1.8 -2.1 -1.7 -1.3 -0.8 -119 -6.0 -73 – – –
– 3.2 4.3 3.8 3.9 3.7 3.0 2.2 1.4 1.1 0.7 0.6 0.5 1.3 1.2 2.7 6.0 6.0 4.6 3.4 5.6 4.5 3.9 3.4 – – –
2.7 5.4 7.2 8.4 7.7 5.8 5.9 5.1 4.4 4.2 2.8 8.2 9.5 11 25 8.9 9.4 7.6 9.4 16 15 19 25 16 56 60 54
2.1 4.3 5.8 6.5 5.2 3.4 3.7 3.0 2.9 3.0 1.5 2.4 1.7 1.4 7.7 6.6 6.9 4.7 6.2 10.0 6.8 11 17 12 26 20 23
– – – – – 0.4 1.0 – 1.3 2.4 – – – – – 2.9 – – 0.3 – 0.6 0.6 0.8 0.6 0.6 0.4 0.5
1.6 1.3 2.3 4.9 1.6 1.4 1.1 0.8 0.9 0.5 0.2 0.5 0.2 0.4 0.7 1.5 2.0 1.3 3.4 2.9 1.1 1.4 4.6 1.8 3.5 1.8 2.4
– – – – – – – – – – – – – – – – – – – 3.0 – – – – – – –
13 93 80 69 60 50 36 26 17 10 27 28 20 18 32 106 90 64 29 37 38 120 107 78 66 55 103
-15 -53 -68 -81 -92 -106 -120 -133 -145 -157 -161 -168 -180 -194 -208 -219 -239 -271 -308 -331 -358 -388 -422 -456 -475 -489 -453
14 14 26 26 26 27 28 28 28 28 29 33 34 36 39 48 50 51 51 55 64 80 84 87 88 90 94

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?